Biological Resolution of Virulence Genes of Salmonella Species from different Microbiomes

The pathogenic promiscuity of virulence associated macromolecules in Salmonella infection is a key driver to their wide epidemiology and curtailing  such distribution is contingent upon proper clarification of these virulence genes. This study was therefore aimed at determining the virulence  genes of Salmonella species from different microbiomes. To achieve this, a total of three hundred (300) biological specimens were aseptically  collected and processed for Salmonella presence using the BAM USFDA technique prior to their genotypic characterization while virulence gene  detection was carried out in a primer specific polymerase chain reaction. Results obtained depict the distribution of the following Salmonella species  viz; Salmonella gallinarum 19(26.39%), Salmonella heidelberg 19(26.39%), Salmonella enteritidis 18(25%) and Salmonella typhimurium  16(22.22%) while the occurrence of the virulence genes (InvA, SopE, AgfA and SpvC) were Salmonella enteritidis ( 7(38.8), 6(33.3), 9(50), 3(16.7),  Salmonella typhimurium ( 5(26.3), 3(15.8), 2(10.5), 7(36.8)), Salmonella heidelberg (0(0), 8(50), 4(25), 4(25), and Salmonella gallinarum (12(63.2),  6(31.6), 2(10.5), 7(36.8)) respectively. It was however found that the different microbiomes analyzed were ubiquitously rich in virulence genes  associated Salmonella species.   La promiscuité pathogène des macromolécules associées à la virulence dans l’infection à Salmonella est un facteur clé de leur large épidémiologie  et la réduction de cette distribution dépend de la clarification appropriée de ces gènes de virulence. Cette étude visait donc à déterminer les gènes  de virulence des espèces de Salmonella de différents microbiomes. Pour ce faire, un total de trois cents (300) échantillons biologiques ont été  collectés et traités de manière aseptique pour la présence de Salmonella à l’aide de la technique BAM USFDA avant leur caractérisation génotypique  tandis que la détection du gène de virulence a été effectuée dans une réaction en chaîne par polymérase spécifique à l’amorce. Les résultats  obtenus décrivent la distribution des espèces de Salmonella suivantes, à savoir ; Salmonella gallinarum 19(26,39%), Salmonella heidelberg  19(26,39%), Salmonella enteritidis 18(25%) et Salmonella typhimurium 16(22,22%) alors que la présence des gènes de virulence (InvA, SopE, AgfA et  SpvC) était Salmonella enteritidis ( 7(38,8), 6(33,3), 9(50), 3(16,7), Salmonella typhimurium ( 5(26,3), 3(15,8), 2(10,5), 7(36,8)), Salmonella heidelberg (0(  0), 8(50), 4(25), 4(25) et Salmonella gallinarum (12(63.2), 6(31.6), 2(10.5), 7(36.8)) respectivement. différents microbiomes analysés étaient  ubiquitairement riches en gènes de virulence associés aux espèces de Salmonella  &nbsp

Impact of depth of clinical response on outcomes of acute myeloid leukemia patients in first complete remission who undergo allogeneic hematopoietic cell transplantation

Acute myeloid leukemia (AML) patients often undergo allogeneic hematopoietic cell transplantation (alloHCT) in first complete remission (CR). We examined the effect of depth of clinical response, including incomplete count recovery (CRi) and/or measurable residual disease (MRD), in patients from the Center for International Blood and Marrow Transplantation Research (CIBMTR) registry. We identified 2492 adult patients (1799 CR and 693 CRi) who underwent alloHCT between January 1, 2007 and December 31, 2015. The primary outcome was overall survival (OS). Multivariable analysis was performed to adjust for patient-, disease-, and transplant-related factors. Baseline characteristics were similar. Patients in CRi compared to those in CR had an increased likelihood of death (HR: 1.27; 95% confidence interval: 1.13-1.43). Compared to CR, CRi was significantly associated with increased non-relapse mortality (NRM), shorter disease-free survival (DFS), and a trend toward increased relapse. Detectable MRD was associated with shorter OS, shorter DFS, higher NRM, and increased relapse compared to absence of MRD. The deleterious effects of CRi and MRD were independent. In this large CIBMTR cohort, survival outcomes differ among AML patients based on depth of CR and presence of MRD at the time of alloHCT. Further studies should focus on optimizing post-alloHCT outcomes for patients with responses less than CR